
China develops 100+ cancer vaccines amid market frenzy
The story in brief
China is speeding up development of Moderna-style cancer vaccines, with over 100 programs underway by biotech firms. Analysts say rapid, affordable production remains uncertain. Cui Cui of Jefferies noted, “China is moving quickly and has already built a large pipeline of more than 100 cancer vaccine programmes.” The rush highlights growing interest in personalized treatments, though scalability and affordability challenges persist.